Global Liraglutide Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch"s in-depth investigation and research, the global Liraglutide market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Liraglutide market has changed rapidly in the past few years. By 2025, China"s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Liraglutide is a medication that belongs to the class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 agonists). It is primarily used to manage blood sugar levels in adults with type 2 diabetes. Liraglutide works by mimicking the effects of a natural hormone called glucagon-like peptide-1, which helps regulate blood sugar levels by stimulating insulin secretion, reducing appetite, and slowing down the emptying of the stomach. In addition to its glucose-lowering effects, liraglutide has also been approved for weight management in individuals who are obese or overweight and have certain weight-related medical conditions. It is administered as a once-daily injection and has demonstrated effectiveness in improving glycemic control and promoting weight loss in clinical studies.
The major global manufacturers of Liraglutide include HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide, AmbioPharm, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Liraglutide. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Liraglutide market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Liraglutide market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Liraglutide industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Liraglutide Include:
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
Liraglutide Product Segment Include:
Liraglutide Pills
Liraglutide Injection
Liraglutide Product Application Include:
Hospital
Drug Store
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Liraglutide Capacity and Production Analysis
Chapter 3: Global Liraglutide Industry PESTEL Analysis
Chapter 4: Global Liraglutide Industry Porter's Five Forces Analysis
Chapter 5: Global Liraglutide Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 6: Global Liraglutide Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 7: Global Liraglutide Sales, Revenue, Price and Forecast by Product Type
Chapter 8: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 9: Industrial Chain Analysis, Liraglutide Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 10: Research Findings and Conclusion
Chapter 11: Methodology and Data Sources
According to DIResearch"s in-depth investigation and research, the global Liraglutide market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Liraglutide market has changed rapidly in the past few years. By 2025, China"s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Liraglutide is a medication that belongs to the class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 agonists). It is primarily used to manage blood sugar levels in adults with type 2 diabetes. Liraglutide works by mimicking the effects of a natural hormone called glucagon-like peptide-1, which helps regulate blood sugar levels by stimulating insulin secretion, reducing appetite, and slowing down the emptying of the stomach. In addition to its glucose-lowering effects, liraglutide has also been approved for weight management in individuals who are obese or overweight and have certain weight-related medical conditions. It is administered as a once-daily injection and has demonstrated effectiveness in improving glycemic control and promoting weight loss in clinical studies.
The major global manufacturers of Liraglutide include HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide, AmbioPharm, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Liraglutide. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Liraglutide market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Liraglutide market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Liraglutide industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Liraglutide Include:
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
Liraglutide Product Segment Include:
Liraglutide Pills
Liraglutide Injection
Liraglutide Product Application Include:
Hospital
Drug Store
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Liraglutide Capacity and Production Analysis
Chapter 3: Global Liraglutide Industry PESTEL Analysis
Chapter 4: Global Liraglutide Industry Porter's Five Forces Analysis
Chapter 5: Global Liraglutide Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 6: Global Liraglutide Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 7: Global Liraglutide Sales, Revenue, Price and Forecast by Product Type
Chapter 8: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 9: Industrial Chain Analysis, Liraglutide Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 10: Research Findings and Conclusion
Chapter 11: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Liraglutide Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Liraglutide Product by Type
- 1.2.1 Liraglutide Pills
- 1.2.2 Liraglutide Injection
- 1.3 Liraglutide Product by Application
- 1.3.1 Hospital
- 1.3.2 Drug Store
- 1.4 Global Liraglutide Market Revenue and Sales Analysis
- 1.4.1 Global Liraglutide Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Liraglutide Sales Market Sales Analysis (2020-2032)
- 1.4.3 Global Liraglutide Market Sales Price Trend Analysis (2020-2032)
- 1.5 Liraglutide Market Development Status and Trends
- 1.5.1 Liraglutide Industry Development Status Analysis
- 1.5.2 Liraglutide Industry Development Trends Analysis
- 2 Global Liraglutide Capacity and Production Analysis
- 2.1 Global Liraglutide Capacity, Production and Utilization (2020-2032)
- 2.2 Global Liraglutide Production Growth Trend by Region: 2024 VS 2025 VS 2032
- 2.3 Global Liraglutide Production by Region
- 2.3.1 Global Liraglutide Production by Region (2020-2025)
- 2.3.2 Global Liraglutide Production Forecast by Region (2026-2032)
- 2.3.3 Global Liraglutide Production Market Share by Region (2020-2032)
- 3 Liraglutide Market PESTEL Analysis
- 3.1 Political Factors Analysis
- 3.2 Economic Factors Analysis
- 3.3 Social Factors Analysis
- 3.4 Technological Factors Analysis
- 3.5 Environmental Factors Analysis
- 3.6 Legal Factors Analysis
- 4 Liraglutide Market Porter's Five Forces Analysis
- 4.1 Competitive Rivalry
- 4.2 Threat of New Entrants
- 4.3 Bargaining Power of Suppliers
- 4.4 Bargaining Power of Buyers
- 4.5 Threat of Substitutes
- 5 Global Liraglutide Market Analysis by Country
- 5.1 Global Liraglutide Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 5.1.1 Global Liraglutide Revenue and Market Share by Country (2020-2025)
- 5.1.2 Global Liraglutide Revenue and Market Share Forecast by Country (2026-2032)
- 5.2 Global Liraglutide Sales Analysis by Country: 2024 VS 2025 VS 2032
- 5.2.1 Global Liraglutide Sales and Market Share by Country (2020-2025)
- 5.2.2 Global Liraglutide Sales and Market Share Forecast by Country (2026-2032)
- 5.3 United States Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 5.4 Germany Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 5.5 Japan Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 5.6 China Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 5.7 France Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 5.8 U.K. Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 5.9 South Korea Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 5.10 Canada Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 5.11 Italy Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 5.12 Russia Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 5.13 Mexico Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 5.14 Brazil Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 5.15 India Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 5.16 Vietnam Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 5.17 Thailand Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 5.18 South Africa Liraglutide Market Sales, Revenue and Growth Rate (2020-2032)
- 6 Competition by Manufacturers
- 6.1 Global Liraglutide Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 6.1.1 Global Liraglutide Market Sales by Key Manufacturers (2021-2025)
- 6.1.2 Global Liraglutide Market Revenue by Key Manufacturers (2021-2025)
- 6.1.3 Global Liraglutide Average Sales Price by Manufacturers (2021-2025)
- 6.2 Liraglutide Competitive Landscape Analysis and Market Dynamic
- 6.2.1 Liraglutide Competitive Landscape Analysis
- 6.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 6.2.3 Market Dynamic
- 7 Liraglutide Market Analysis by Type
- 7.1 Global Liraglutide Market Revenue Analysis by Type
- 7.1.1 Global Liraglutide Market Size Analysis by Type: 2024 & 2025 & 2032
- 7.1.2 Global Liraglutide Revenue and Forecast Analysis by Type (2020-2032)
- 7.2 Global Liraglutide Market Sales and Forecast Analysis by Type (2020-2032)
- 7.3 Global Liraglutide Sales Price Trend Analysis by Type (2020-2032)
- 8 Key Companies Analysis
- 8.1 HEC Pharm
- 8.1.1 HEC Pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 8.1.2 HEC Pharm Liraglutide Product Portfolio
- 8.1.3 HEC Pharm Liraglutide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8.2 Bachem
- 8.2.1 Bachem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 8.2.2 Bachem Liraglutide Product Portfolio
- 8.2.3 Bachem Liraglutide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8.3 Bharat Pharmaceuticals
- 8.3.1 Bharat Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 8.3.2 Bharat Pharmaceuticals Liraglutide Product Portfolio
- 8.3.3 Bharat Pharmaceuticals Liraglutide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8.4 Kingpep Biotechnology
- 8.4.1 Kingpep Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 8.4.2 Kingpep Biotechnology Liraglutide Product Portfolio
- 8.4.3 Kingpep Biotechnology Liraglutide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8.5 Shenzhen JYMed Technology
- 8.5.1 Shenzhen JYMed Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 8.5.2 Shenzhen JYMed Technology Liraglutide Product Portfolio
- 8.5.3 Shenzhen JYMed Technology Liraglutide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8.6 Wuxi Asiapeptide
- 8.6.1 Wuxi Asiapeptide Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 8.6.2 Wuxi Asiapeptide Liraglutide Product Portfolio
- 8.6.3 Wuxi Asiapeptide Liraglutide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8.7 AmbioPharm
- 8.7.1 AmbioPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 8.7.2 AmbioPharm Liraglutide Product Portfolio
- 8.7.3 AmbioPharm Liraglutide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 9 Industry Chain Analysis
- 9.1 Liraglutide Industry Chain Analysis
- 9.2 Liraglutide Industry Upstream Supply Analysis
- 9.2.1 Upstream Key Raw Material Supply Analysis
- 9.2.2 Raw Material Suppliers and Contact Information
- 9.3 Liraglutide Product Downstream Application Analysis
- 9.3.1 Global Liraglutide Revenue Market Size by Application: 2024 VS 2025 VS 2032
- 9.3.2 Global Liraglutide Revenue and Forecast Analysis by Application (2020-2032)
- 9.3.3 Global Liraglutide Sales and Forecast Analysis by Application (2020-2032)
- 9.4 Liraglutide Typical Downstream Customers
- 9.5 Liraglutide Sales Channel Analysis
- 10 Research Findings and Conclusion
- 11 Methodology and Data Source
- 11.1 Methodology/Research Approach
- 11.2 Research Scope
- 11.3 Benchmarks and Assumptions
- 11.4 Date Source
- 11.4.1 Primary Sources
- 11.4.2 Secondary Sources
- 11.5 Data Cross Validation
- 11.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
